2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma
6
Urogenital Neoplasms
5
Prostatic Neoplasms
5
Prostatic Diseases
5
Neoplasms by Site
5
Neoplasms
5
Male Urogenital Diseases
5
Genital Neoplasms, Male
5
Genital Diseases, Male
4
Transitional Cell Cancer of Renal Pelvis and Ureter
1
Lung Neoplasms
1
Localized Prostate Cancer
1
Genital Diseases
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
padeliporfin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Transitional Cell Cancer of Renal Pelvis and Ureter
×
padeliporfin
×
Clear all
NCT04620239
2026-02-04
UCM301
Steba Biotech S.A.
Phase 3
Recruiting
100 enrolled